Read the newsletter
Keep up with the latest news, updates and insights on our work. We also cover infrastructure development in Flemingsberg. Subscribe to our newsletter. Sign up here!
Newsletter archive
Below older issues of the newsletter.
Neighbors in collaboration: New partnerships emerge at Novum Labs
At Novum Labs, companies developing tomorrow’s solutions for human health come together. Side by side – and sometimes with each other’s help. OptiCell Solutions and Circio are the neighbors who turned proximity into collaboration.
Samplimy wins Money Talks Pitch Competition: aiming to transform the future of sampling
With a technology that enables painless and more accessible sampling, Samplimy took home first prize in the Money Talks Pitch Competition at the second Life Science Fair Flemingsberg of the year.
A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated
With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.
Touchdown Novum Labs for Hydromars!
A new company has arrived in Flemingsberg, and they´re moving at rocket speed on their journey toward space. Meet Hydromars, the startup company developing a system for water purification and nutrient recovery, with a grand goal of enabling sustainable human presence in space.
ATMP Sweden – now also in Flemingsberg!
The ATMP Sweden association carries out dedicated work focused on national coordination and communication to accelerate the development, accessibility, and implementation of advanced therapies (ATMP). And now they also have an office space at Novum Labs! From here, Henrik Simonsson, Communications and Operative Lead, can work on the association’s plans to take its operations to even more meaningful heights.
AlzeCure Pharma – a hope in the fight against Alzheimer’s
Neurological diseases and the pain area are struggling with great medical needs, including the lack of broad-spectrum drugs. Those are gaps in the market that AlzeCure Pharma wants to fill, and they are well on their way. They recently received a grant from the European Innovation Council (EIC) to finance a clinical phase 2 study of the drug candidate NeuroRestore ACD856 for Alzheimer’s disease.
